News ZIM Laboratories Limited

Equities

ZIMLAB

INE518E01015

Delayed Bombay S.E. Other stock markets 00:48:16 2024-05-09 EDT			5-day change	1st Jan Change
115.4 ^INR	+0.39%		-5.02%	+0.17%

01-29	ZIM Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
2023	ZIM Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ZIM Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01-29	CI
ZIM Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-01	CI
Zim Laboratories Arm Gets License to Operate Business in Dubai, UAE	23-10-16	MT
ZIM Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
ZIM Laboratories Limited agreed to acquire 99% stake in Zimtas Pty Ltd for approximately AUD 0.01 million.	23-06-27	CI
CARE Gives BBB Rating to Zim Laboratories' Long-term Bank Financing; Outlook Stable	23-06-06	MT
ZIM Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-19	CI
ZIM Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-19	CI
ZIM Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-03	CI
ZIM Laboratories Issues Over 32 Million Bonus Shares	22-12-23	MT
ZIM Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-12	CI
Acuite Retains BBB- Rating on Zim Laboratories' Bank Loans; Raises Outlook to Positive	22-08-30	MT
ZIM Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-07-26	CI
ZIM Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-05-21	CI
ZIM Laboratories Limited Announces Grant of Marketing Authorization for Sildenafil Citrate 50 mg Orally Dissolving Film in Spain, Europe	22-05-12	CI
ZIM Laboratories Limited Announces Board Changes, Effective April 1, 2022	22-03-31	CI
ZIM Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-10-30	CI
ZIM Laboratories : Acuite Ratings & Research Upgrades Zim Laboratories' Rating to BBB-; Keeps Stable Outlook	21-09-23	MT
ZIM Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	21-08-13	CI
Zim Laboratories' : European Arm Gets Approval to Market Migraine Drug Rizatriptan in Portugal	21-07-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ZIM Laboratories Limited

Equities

ZIMLAB

INE518E01015

Summary

Filters